Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Targovax: Presentation material for today's webcast


OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax will at 14:00 CEST today host a live webcast presentation held by the company's newly appointed CEO Erik Digman Wiklund.

Webcast URL: https://inqrate.com/xtravideos/targovax-trvx-presentasjon-25-oktober/

Presentation material: Targovax presentation

The presentation will be followed by a Q&A session moderated by analyst in DNB Markets Patrik Ling. Webcast viewers are welcome to submit questions in advance or during the presentation to [email protected].

A replay of the webcast will be available at https://www.targovax.com.

CONTACT:

For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 906 56 525
Email: [email protected]

Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: [email protected]

Media enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773
Email: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/targovax/r/targovax--presentation-material-for-today-s-webcast,c3439315

The following files are available for download:

https://mb.cision.com/Public/17093/3439315/a623e25c650c634d.pdf

211025 XtraInvestor Targovax web

SOURCE Targovax


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: